Bharat Parenterals Ltd.
Snapshot View

View in App

Prices View details >>

318.00 +5.00 ▲1.6%

28 September 2022, 11:20:00 AM
Volume: 502

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bplindia.in
Market Cap 178.44 Cr.
Enterprise Value(EV) 193.82 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 25.11 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 12.31 Trailing Twelve Months Ending 2022-06
Industry PE 30.69 Trailing Twelve Months Ending 2022-06
Book Value / Share 287.13 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.08 Calculated using Price: 309.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.58 Cr. 5,774,666 Shares
FaceValue 10
Company Profile
The company is engaged in to the business of the Pharmaceuticals & Drugs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.60%
1 Week
-3.39%
1 Month
-2.66%
3 Month
-4.50%
6 Month
-2.51%
1 Year
-14.95%
2 Year
-21.20%
5 Year
10 Year

Ratios View Details >>

6 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 11.38 11.45 13.35 25.47 22.76 15.53
Return on Capital Employed (%) 14.23 11.47 18.10 39.30 30.83 20.24
Return on Assets (%) 5.37 5.99 7.61 14.71 13.94 10.52

Balance Sheet View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 57 64 73 94 118 144 166
Non Curr. Liab. 7 3 0 4 3 11 14
Curr. Liab. 56 43 57 61 66 44 42
Minority Int. 0 4
Equity & Liab. 120 110 130 159 188 199 226
Non Curr. Assets 49 46 39 41 56 51 82
Curr. Assets 72 64 91 118 132 148 144
Misc. Exp. not W/O
Total Assets 120 110 130 159 188 199 226

Profit Loss View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 124 111 137 220 228 205 177
Other Income 5 8 7 13 12 9 8
Total Income 129 119 144 232 240 213 185
Total Expenditure -114 -105 -124 -191 -201 -179 -158
PBIDT 15 14 19 42 40 34 26
Interest -1 -1 -1 -1 -1 -1 -1
Depreciation -4 -6 -6 -6 -6 -6 -6
Taxation -3 -1 -4 -13 -9 -7 -5
Exceptional Items
PAT 6 7 9 21 24 20 14
Minority Interest 0 0
Share Associate
Other Related Items
Consolidated Net Profit 6 7 9 21 24 20 15
Adjusted EPS 11 12 16 37 42 36 25

Cash Flow View Details >>

Particulars 6 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -2 6 20 14 31
Cash Fr. Inv. -2 -8 -9 -13 -48
Cash Fr. Finan. -8 4 -4 -3 8
Net Change -11 2 7 -1 -8
Cash & Cash Eqvt 2 4 11 10 2

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 74.42 74.42 74.42 74.42 74.42 74.42 74.42 73.84 73.84
Public 25.58 25.58 25.58 25.58 25.58 25.58 25.58 26.16 26.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 27 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
As per the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 proceedings of the 29th Annual General Meeting held on 27th September 2022 through Video Conferencing (VC)/other audio visual means (OAVM) of the Company is enclosed herewith.
Wed, 07 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 47 of SEBI (Listing Obligation and Disclosures requirement) Regulation 2015 the company has published the Notice of 29th Annual General Meeting of the company scheduled to be held on 27th September 2022 at 10:30 A.M. (IST) through Video conferencing (VC) or Other Audio Visual Means (OAVM) in the following newspapers:1. Loksatta Jansatta 2. Business Standard
Fri, 02 Sep 2022
Reg. 34 (1) Annual Report.
We submit herewith 29th Annual Report of the company for the FY 2021-2022 together with the Notice of 29th Annual General Meeting of the company scheduled to be held on 27th September 2022 at 10:30 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) in accordance with the relevant circulars issued by Ministry of Corporate Affairs (MCA) and SEBI.The said Annual Report along with the Notice is also available on the website of the company www.bplindia.in A copy of the Annual Report is being mailed to all the shareholders of the company whose E-Mails IDs are registered with the company/R&T Agents & DPs.

Technical Scans View Details >>

Tue, 27 Sep 2022
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
5 SMA Crossing 20 SMA From Above 5 SMA Crossing 20 SMA From Above
CCI Crossed Below -100 CCI Crossed Below -100
CCI Oversold Zone CCI Oversold Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 215,220.35 923.75 +3.0%
Divi's Laboratories Ltd. 97,697.75 3,689.75 +0.3%
Cipla Ltd. 88,665.27 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. 69,609.45 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. 61,007.11 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. 51,942.91 1,487.00 -3.0%
Max Healthcare Institute Ltd. 40,110.70 409.10 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.33 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.40 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-06 35.70 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.30 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.06 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.85 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 63.58 409.10 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.30 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.84 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-06 4.13 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.44 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.27 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.13 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.24 409.10 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 409.10 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.10 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.10 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 409.10 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 923.75 +3.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,689.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,098.00 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,249.45 +1.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,284.35 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,487.00 -3.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 409.10 -1.1%

FAQ's On Bharat Parenterals Ltd.

What is Bharat Parenterals share price?
Can I buy Bharat Parenterals shares now?
What is the Market Cap of Bharat Parenterals?
What are the key metrics to analyse Bharat Parenterals?
What is the 52 Week High and Low of Bharat Parenterals?
What is the trend of Bharat Parenterals share price?